Article Text

other Versions

PDF
Ophthalmic patients on antithrombotic drugs: a review and guide to perioperative management
  1. K-L Kong1,
  2. J Khan2
  1. 1Department of Anaesthesia, SWBH NHS Trust, Birmingham, UK
  2. 2Department of Cardiology, SWBH NHS Trust, Birmingham, UK
  1. Correspondence to Dr K-L Kong, Department of Anaesthesia, SWBH NHS Trust, Birmingham B18 7QH, UK; k-l.kong{at}nhs.net

Abstract

The changing profile of patients undergoing ophthalmic surgery, with an increase in prevalence of antiplatelet and anticoagulant drug use, predisposes to bleeding complications. This mandates an awareness of these agents, allowing optimal patient management. We review traditional and newer agents in the context of cataract, vitreoretinal, glaucoma and oculoplastic surgery. Recommendations are given for continuation, cessation and re-commencement of these agents in order to minimise the risk of bleeding and thrombotic/thromboembolic complications.

  • Drugs
  • Glaucoma
  • Pharmacology
  • Posterior Chamber
  • Treatment Surgery

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.